Table 2 Clinical information for women whose NAF samples passed quality filtering.
From: Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors
Healthy Control Women (HC) | Women with a History of Breast Cancer (BC) | ||
|---|---|---|---|
Age | average (range) | 52 (41 to 64) | 58 (52 to 66) |
Caucasian | n (%) | 6 (100%) | 6 (100%) |
BMI | average ± SD (range) | 25.6 ± 8.1 (19.5 to 35.1) | 24.3 ± 4.6 (20.6 to 31.3) |
Menopausal status | n (%) | ||
Pre-menopausal | 2 (33.3%) | 1 (16.7%) | |
Peri-menopausal | 1 (16.7%) | 1 (16.7%) | |
Post-menopausal | 3 (50.0%) | 4 (66.6%) | |
Estrogen Receptor (ER) | n (%) | ||
Positive | NA | 3 (50.0%) | |
Negative | NA | 3 (50.0%) | |
Progesterone Receptor (PR) | n (%) | ||
Positive | NA | 1 (16.7%) | |
Negative | NA | 2 (33.3%) | |
Unknown | NA | 3 (50.0%) | |
Human Epidermal Growth Factor Receptor 2 (HER2) | n (%) | ||
Positive | NA | 3 (50.0%) | |
Negative | NA | 3 (50.0%) | |
Breast Feed | n (%) | ||
Yes | 2 (33.3%) | 3 (50.0%) | |
No | 4 (66.7%) | 2 (33.3%) | |
Unknown | 0 (00.0%) | 1 (16.7%) | |
Antibiotics in the Past Year | n (%) | ||
Yes | 3 (50.0%) | 1 (16.6%) | |
No | 3 (50.0%) | 4 (66.7%) | |
Unknown | 0 (00.0%) | 1 (16.7%) | |
Hormone therapy/Oral contraceptive | n (%) | ||
Yes | 3 (50.0%) | 2 (33.3%) | |
No | 3 (50.0%) | 3 (50.0%) | |
Unknown | 0 (00.0%) | 1 (16.7%) | |
Recent Breast Exposure to Mouth by Breast-feeding/Sex | n (%) | ||
Yes | 3 (50.0%) | 3 (50.0%) | |
No | 3 (50.0%) | 2 (33.3%) | |
Unknown | 0 (00.0%) | 1 (16.7%) | |
Mother had Breast Cancer | n (%) | ||
Yes | 2 (33.3%) | 1 (16.7%) | |
No | 4 (66.7%) | 4 (66.7%) | |
Unknown | 0 (00.0%) | 1 (16.7%) | |
Dense Breast Tissue on Mammogram | n (%) | ||
Yes | 4 (66.7%) | 3 (50.0%) | |
No | 2 (33.3%) | 1 (16.7%) | |
Unknown | 0 (00.0%) | 2 (33.3%) |
